BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36416121)

  • 41. Analysis of Tolfenamic Acid using a Simple, Rapid, and Stability-indicating Validated HPLC Method.
    Kazi SH; Sheraz MA; Musharraf SG; Ahmed S; Bano R; Haq FU; Anwar Z; Ali R
    Antiinflamm Antiallergy Agents Med Chem; 2024; 23(1):52-70. PubMed ID: 37291774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
    Vojta J; Jedlička A; Coufal P; Janečková L
    J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RP-HPLC Method for the Simultaneous Determination of a Quaternary Mixture of Propyphenazone, Flavoxate HCl and Two of Their Official Impurities with Dissolution Profiling of Their Tablets.
    El-Ragehy NA; Ramadan NK; Ragab MT; El-Zeany BA
    J AOAC Int; 2020 Jul; 103(4):958-965. PubMed ID: 33241355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C.
    Vemuri DK; Akshinthala P; Konduru N; Kowtharapu LP; Katari NK; Jonnalagadda SB; Gundla R
    ACS Omega; 2022 Dec; 7(51):47650-47661. PubMed ID: 36591161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A validated, stability-indicating HPLC method for the determination of dexamethasone related substances on dexamethasone-coated drug-eluting stents.
    Chen Q; Zielinski D; Chen J; Koski A; Werst D; Nowak S
    J Pharm Biomed Anal; 2008 Nov; 48(3):732-8. PubMed ID: 18722070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of a simple and sensitive HPLC method for the determination of related substances in regorafenib tablets.
    Li S; Jiang M; Li M; Hu P; Xu M; Shu C
    Anal Sci; 2022 Mar; 38(3):591-599. PubMed ID: 35286636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of an efficient stability-indicating LC-MS/MS method for the analysis of selexipag and characterization of its degradation products.
    Amara Babu NLA; Koganti K; Palakeeti B; Srinivas KSV; Rao KP
    Biomed Chromatogr; 2021 Oct; 35(10):e5178. PubMed ID: 33998014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A simple stability indicating RP-HPLC-DAD method for concurrent analysis of Tenofovir Disoproxil Fumarate, Doravirine and Lamivudine in pure blend and their combined film coated tablets.
    Godela R; Gummadi S
    Ann Pharm Fr; 2021 Nov; 79(6):640-651. PubMed ID: 34019910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) method for the determination of related substances of micafungin sodium in drug substances.
    Zhu S; Meng X; Su X; Luo Y; Sun Z
    Int J Mol Sci; 2013 Oct; 14(11):21202-14. PubMed ID: 24284389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method.
    Mantripragada MKVVN; Rao SV; Nutulapati VVS; Mantena BPV
    J Chromatogr Sci; 2018 Mar; 56(3):270-284. PubMed ID: 29300835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation.
    Reddy PS; Sudhakar Babu K; Kumar N
    J Chromatogr Sci; 2013 Mar; 51(3):242-9. PubMed ID: 22988002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development and Validation of a RP-HPLC Method for Determination of Related Substances and Degradants in Entacapone.
    Purnachand D; Veerareddy A; Ramadevi B; Kameswarrao ChV; Madhusudhanreddy B
    J Chromatogr Sci; 2016 Sep; 54(8):1310-23. PubMed ID: 27165569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
    Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
    J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of a stability-indicating RP-HPLC method for the identification, determination of related substances and assay of dimethyl fumarate in drug substance.
    Kommareddy S; Nigam RS; Kumar S
    Ann Pharm Fr; 2021 Mar; 79(2):179-193. PubMed ID: 33091397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC.
    Djurdjevic P; Ciric A; Djurdjevic A; Stankov MJ
    J Pharm Biomed Anal; 2009 Sep; 50(2):117-26. PubMed ID: 19464135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid Development and Validation of Improved Reversed-Phase High-performance Liquid Chromatography Method for the Quantification of Mangiferin, a Polyphenol Xanthone Glycoside in
    Naveen P; Lingaraju HB; Prasad KS
    Pharmacognosy Res; 2017; 9(2):215-219. PubMed ID: 28539748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities.
    Ferrarini A; Huidobro AL; Pellati F; Barbas C
    J Pharm Biomed Anal; 2010 Oct; 53(2):122-9. PubMed ID: 20138727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
    Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
    Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of stability-indicating -HPLC method for the determination of related substances in novel nitroimidazole antituberculosis drug pretomanid: Robustness study by Design-Expert and application to stability studies.
    Surapuraju PKR; Juturu RR
    Biomed Chromatogr; 2022 Dec; 36(12):e5498. PubMed ID: 36065902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.